فهرس الدراسات بحسب الترتيب الأبجدي
فهرس:
هل راميبريل حقيقة افضل من مثبطات الخميرة المحولة للانجيوتنسين الاخرى بعد احتشاء العضلة القلبية الحاد
Whether angiotensin-converting enzyme (ACE) inhibitors are interchangeable and equally efficacious after acute myocardial infarction (AMI) is controversial. We assessed whether ramipril was superior to other ACE inhibitors after AMI as suggested by a previously published study. We performed...
التفاصيل
تاثير تخفيض الكولسترول عند الاشخاص المتوسطي الخطورة و ليس لديهم امراض قلبية وعائية
BACKGROUND Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inflammatory markers and involved mainly...
التفاصيل
ايزواوميبرازول و رابيبرازول لا يقللون التاثير المضاد للصفيحات للاسبيرين/كلوبيدوبريل عند المرضى المجرى لهم قثطرة تاجية
Objectives: Controversy has been prompted based on drug interaction between proton pump inhibitors (PPIs) and aspirin/clopidogrel leading to weakened effects. However, whether such interaction was drug-specific or class effect remains controversial. This study predicted the impact of esomeprazole and...
التفاصيل
Effect of telmisartan on kidney function in patients with chronic kidney disease: an observational study
Background: Globally the burden of chronic kidney disease (CKD) is rising, an important cause of death and loss of disability-adjusted life years. Activation of the renin-angiotensin-aldosterone system is involved in its pathogenesis. The aim of...
التفاصيل
Ramipril and hydrochlorothiazide treatment of hypertensive urgency in the ED
Hypertensive urgencies are a frequent cause for consultation at the emergency department (ED). There are multiple approaches to treating this presentation, and we endeavored to assess the safety and efficacy of an oral treatment with...
التفاصيل
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
Background: The Study of Micardis (telmisartan) in Overweight/Obese patients with Type 2 diabetes and Hypertension (SMOOTH) compared hydrochlorothiazide (HCTZ) plus telmisartan or valsartan fixed-dose combination therapies on early morning blood pressure (BP), using ambulatory BP...
التفاصيل